ofloxacin has been researched along with cefoxitin sodium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, S; Chen, Q; Du, D; Du, Q; Duan, F; Fan, C; Guo, X; He, S; He, Y; Huang, B; Huang, W; Ji, C; Li, X; Liang, Y; Liu, X; Liu, Y; Ma, L; Wang, Y; Wei, Z; Wu, X; Xin, G; Xing, Z; Zeng, D; Zhang, R; Zhao, H | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
2 other study(ies) available for ofloxacin and cefoxitin sodium
| Article | Year |
|---|---|
Haloemodin as novel antibacterial agent inhibiting DNA gyrase and bacterial topoisomerase I.
Topics: Animals; Anti-Bacterial Agents; Emodin; Enterococcus faecium; Keratitis; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Rabbits; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2014 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |